02096 SIMCERE PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.00X | Oper Margin | 13.4% |
|---|---|---|---|
| LT Debt/Equity | 1.3% | Net Margin | 11.1% |
| Total Debt/Equity | 17.1% | Return on Equity | 10.4% |
| Price/Book | 4.03X | Return on Assets | 6.4% |
| (HKD 11.980) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 779.72 | 787.81 | 1,043.69 | 1,843.33 | 794.60 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -1.0 | -24.5 | -43.4 | +132.0 | -29.2 |
| Earnings Per Share (HKD) | 0.31 | 0.302 | 0.4 | 0.707 | 0.332 |
| Earnings Per Share Growth (%) | +2.8 | -24.4 | -43.4 | +112.8 | +100.0 |
| Dividend Per Share (HKD) | 0.175 | 0.176 | 0.176 | 0.176 | 0.180 |
| P/E* (X) | 38.61 | 39.67 | 29.97 | 16.95 | 36.07 |
| Yield (%) | 1.46 | 1.47 | 1.47 | 1.47 | 1.51 |
| Dividend Share (%) | 56.33 | 58.18 | 43.98 | 24.87 | 54.29 |
| Book NAV (HKD) | 2.975 | 3.026 | 3.006 | 2.996 | 2.412 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 6,635 | 6,608 | +0.4 | 6,324 |
| Operating Result | 819.217 | -59.73 | -1,471.5 | 896.635 |
| Associates | 2.162 | 7.844 | -72.4 | 0.19 |
| Profit Before Taxation | 819.878 | 740.038 | +10.8 | 886.254 |
| Taxation | 86.713 | 26.088 | +232.4 | -40.478 |
| Profit /( Loss) After Taxation | 733.165 | 713.95 | +2.7 | 926.732 |
| Minority Interests | 0 | -0.811 | -100.0 | -4.136 |
| Net Profit | 733.165 | 714.761 | +2.6 | 930.868 |
| Earnings Per Share () | 0.3103 | 0.3020 | +2.7 | 0.3997 |
| Dividend Per Share () | 0.1748 | 0.1757 | -0.5 | 0.1758 |
| Announcement Date | 2025-03-24 | 2024-03-20 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
